Why Niagen Bioscience’s next investor meetings could sharpen the NAD+ market debate
NAD+ is hot, but credibility is scarce. Niagen Bioscience now has to prove healthspan science can support durable investor trust.
Pharma & Biotech
Features & Analysis
Standard Process launches Cultivate symposium to advance whole-food nutrition strategies for healthy aging practitioners
Discover why Standard Process’ Cultivate symposium aims to close clinical education gaps in whole-food nutrition and reshape healthy aging care for practitioners.